1 Drug-Eluting Bioabsorbable Stents Market Overview 1.1 Product Overview and Scope of Drug-Eluting Bioabsorbable Stents 1.2 Drug-Eluting Bioabsorbable Stents Segment by Type 1.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Serolimus and Paclitaxel Drug-Eluting Stents 1.2.3 Sirolimus Drug Eluting Stents 1.3 Drug-Eluting Bioabsorbable Stents Segment by Application 1.3.1 Global Drug-Eluting Bioabsorbable Stents Sales Comparison by Application: (2021-2027) 1.3.2 Coronary Artery Diseases 1.3.3 Peripheral Artery Diseases 1.4 Global Drug-Eluting Bioabsorbable Stents Market Size Estimates and Forecasts 1.4.1 Global Drug-Eluting Bioabsorbable Stents Revenue 2016-2027 1.4.2 Global Drug-Eluting Bioabsorbable Stents Sales 2016-2027 1.4.3 Drug-Eluting Bioabsorbable Stents Market Size by Region: 2016 Versus 2021 Versus 2027 2 Drug-Eluting Bioabsorbable Stents Market Competition by Manufacturers 2.1 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2016-2021) 2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Drug-Eluting Bioabsorbable Stents Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Drug-Eluting Bioabsorbable Stents Manufacturing Sites, Area Served, Product Type 2.5 Drug-Eluting Bioabsorbable Stents Market Competitive Situation and Trends 2.5.1 Drug-Eluting Bioabsorbable Stents Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Drug-Eluting Bioabsorbable Stents Players Market Share by Revenue 2.5.3 Global Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario by Region 3.1 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country 3.3.1 North America Drug-Eluting Bioabsorbable Stents Sales by Country 3.3.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country 3.4.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country 3.4.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Region 3.5.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region 3.5.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country 3.6.1 Latin America Drug-Eluting Bioabsorbable Stents Sales by Country 3.6.2 Latin America Drug-Eluting Bioabsorbable Stents Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country 3.7.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country 3.7.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Drug-Eluting Bioabsorbable Stents Historic Market Analysis by Type 4.1 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2016-2021) 4.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2016-2021) 4.3 Global Drug-Eluting Bioabsorbable Stents Price by Type (2016-2021) 5 Global Drug-Eluting Bioabsorbable Stents Historic Market Analysis by Application 5.1 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2016-2021) 5.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2016-2021) 5.3 Global Drug-Eluting Bioabsorbable Stents Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Medtronic 6.1.1 Medtronic Corporation Information 6.1.2 Medtronic Description and Business Overview 6.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Product Portfolio 6.1.5 Medtronic Recent Developments/Updates 6.2 B.Braun Melsungen 6.2.1 B.Braun Melsungen Corporation Information 6.2.2 B.Braun Melsungen Description and Business Overview 6.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Portfolio 6.2.5 B.Braun Melsungen Recent Developments/Updates 6.3 Abbott Laboratories 6.3.1 Abbott Laboratories Corporation Information 6.3.2 Abbott Laboratories Description and Business Overview 6.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Portfolio 6.3.5 Abbott Laboratories Recent Developments/Updates 6.4 Boston Scientific Corporation 6.4.1 Boston Scientific Corporation Corporation Information 6.4.2 Boston Scientific Corporation Description and Business Overview 6.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Portfolio 6.4.5 Boston Scientific Corporation Recent Developments/Updates 6.5 Biosensors International 6.5.1 Biosensors International Corporation Information 6.5.2 Biosensors International Description and Business Overview 6.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Product Portfolio 6.5.5 Biosensors International Recent Developments/Updates 6.6 Terumo Corporation. 6.6.1 Terumo Corporation. Corporation Information 6.6.2 Terumo Corporation. Description and Business Overview 6.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Portfolio 6.6.5 Terumo Corporation. Recent Developments/Updates 6.7 MicroPort Scientific Corporation 6.6.1 MicroPort Scientific Corporation Corporation Information 6.6.2 MicroPort Scientific Corporation Description and Business Overview 6.6.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.4.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Portfolio 6.7.5 MicroPort Scientific Corporation Recent Developments/Updates 6.8 Alvimedica 6.8.1 Alvimedica Corporation Information 6.8.2 Alvimedica Description and Business Overview 6.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Product Portfolio 6.8.5 Alvimedica Recent Developments/Updates 6.9 Biotronik 6.9.1 Biotronik Corporation Information 6.9.2 Biotronik Description and Business Overview 6.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Product Portfolio 6.9.5 Biotronik Recent Developments/Updates 6.10 Elixir Medical Corporation 6.10.1 Elixir Medical Corporation Corporation Information 6.10.2 Elixir Medical Corporation Description and Business Overview 6.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Portfolio 6.10.5 Elixir Medical Corporation Recent Developments/Updates 6.11 Innovative Health Technologies 6.11.1 Innovative Health Technologies Corporation Information 6.11.2 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Description and Business Overview 6.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Portfolio 6.11.5 Innovative Health Technologies Recent Developments/Updates 7 Drug-Eluting Bioabsorbable Stents Manufacturing Cost Analysis 7.1 Drug-Eluting Bioabsorbable Stents Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Drug-Eluting Bioabsorbable Stents 7.4 Drug-Eluting Bioabsorbable Stents Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Drug-Eluting Bioabsorbable Stents Distributors List 8.3 Drug-Eluting Bioabsorbable Stents Customers 9 Drug-Eluting Bioabsorbable Stents Market Dynamics 9.1 Drug-Eluting Bioabsorbable Stents Industry Trends 9.2 Drug-Eluting Bioabsorbable Stents Growth Drivers 9.3 Drug-Eluting Bioabsorbable Stents Market Challenges 9.4 Drug-Eluting Bioabsorbable Stents Market Restraints 10 Global Market Forecast 10.1 Drug-Eluting Bioabsorbable Stents Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Drug-Eluting Bioabsorbable Stents by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Drug-Eluting Bioabsorbable Stents by Type (2022-2027) 10.2 Drug-Eluting Bioabsorbable Stents Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Drug-Eluting Bioabsorbable Stents by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Drug-Eluting Bioabsorbable Stents by Application (2022-2027) 10.3 Drug-Eluting Bioabsorbable Stents Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Drug-Eluting Bioabsorbable Stents by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Drug-Eluting Bioabsorbable Stents by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Drug-Eluting Bioabsorbable Stents Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Drug-Eluting Bioabsorbable Stents Covered in This Study Table 5. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2016-2021) Table 7. Global Drug-Eluting Bioabsorbable Stents Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Drug-Eluting Bioabsorbable Stents Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Drug-Eluting Bioabsorbable Stents Manufacturing Sites and Area Served Table 11. Manufacturers Drug-Eluting Bioabsorbable Stents Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Drug-Eluting Bioabsorbable Stents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Eluting Bioabsorbable Stents as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Drug-Eluting Bioabsorbable Stents Sales by Region (2016-2021) & (K Units) Table 16. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2016-2021) Table 17. Global Drug-Eluting Bioabsorbable Stents Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2016-2021) & (K Units) Table 19. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2016-2021) Table 20. North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2016-2021) Table 22. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2016-2021) & (K Units) Table 23. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2016-2021) Table 24. Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2016-2021) Table 30. Latin America Drug-Eluting Bioabsorbable Stents Sales by Country (2016-2021) & (K Units) Table 31. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2016-2021) Table 32. Latin America Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2016-2021) Table 38. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Type (2016-2021) Table 39. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2016-2021) Table 40. Global Drug-Eluting Bioabsorbable Stents Revenue (Million US$) by Type (2016-2021) Table 41. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Type (2016-2021) Table 42. Global Drug-Eluting Bioabsorbable Stents Price (USD/Unit) by Type (2016-2021) Table 43. Global Drug-Eluting Bioabsorbable Stents Sales (K Units) by Application (2016-2021) Table 44. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2016-2021) Table 45. Global Drug-Eluting Bioabsorbable Stents Revenue (Million US$) by Application (2016-2021) Table 46. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Application (2016-2021) Table 47. Global Drug-Eluting Bioabsorbable Stents Price (USD/Unit) by Application (2016-2021) Table 48. Medtronic Corporation Information Table 49. Medtronic Description and Business Overview Table 50. Medtronic Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Medtronic Drug-Eluting Bioabsorbable Stents Product Table 52. Medtronic Recent Developments/Updates Table 53. B.Braun Melsungen Corporation Information Table 54. B.Braun Melsungen Description and Business Overview Table 55. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Table 57. B.Braun Melsungen Recent Developments/Updates Table 58. Abbott Laboratories Corporation Information Table 59. Abbott Laboratories Description and Business Overview Table 60. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Table 62. Abbott Laboratories Recent Developments/Updates Table 63. Boston Scientific Corporation Corporation Information Table 64. Boston Scientific Corporation Description and Business Overview Table 65. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Table 67. Boston Scientific Corporation Recent Developments/Updates Table 68. Biosensors International Corporation Information Table 69. Biosensors International Description and Business Overview Table 70. Biosensors International Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Biosensors International Drug-Eluting Bioabsorbable Stents Product Table 72. Biosensors International Recent Developments/Updates Table 73. Terumo Corporation. Corporation Information Table 74. Terumo Corporation. Description and Business Overview Table 75. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Table 77. Terumo Corporation. Recent Developments/Updates Table 78. MicroPort Scientific Corporation Corporation Information Table 79. MicroPort Scientific Corporation Description and Business Overview Table 80. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Table 82. MicroPort Scientific Corporation Recent Developments/Updates Table 83. Alvimedica Corporation Information Table 84. Alvimedica Description and Business Overview Table 85. Alvimedica Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Alvimedica Drug-Eluting Bioabsorbable Stents Product Table 87. Alvimedica Recent Developments/Updates Table 88. Biotronik Corporation Information Table 89. Biotronik Description and Business Overview Table 90. Biotronik Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Biotronik Drug-Eluting Bioabsorbable Stents Product Table 92. Biotronik Recent Developments/Updates Table 93. Elixir Medical Corporation Corporation Information Table 94. Elixir Medical Corporation Description and Business Overview Table 95. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Table 97. Elixir Medical Corporation Recent Developments/Updates Table 98. Innovative Health Technologies Corporation Information Table 99. Innovative Health Technologies Description and Business Overview Table 100. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Table 102. Innovative Health Technologies Recent Developments/Updates Table 103. Production Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Drug-Eluting Bioabsorbable Stents Distributors List Table 106. Drug-Eluting Bioabsorbable Stents Customers List Table 107. Drug-Eluting Bioabsorbable Stents Market Trends Table 108. Drug-Eluting Bioabsorbable Stents Growth Drivers Table 109. Drug-Eluting Bioabsorbable Stents Market Challenges Table 110. Drug-Eluting Bioabsorbable Stents Market Restraints Table 111. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2022-2027) & (K Units) Table 112. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Type (2022-2027) Table 113. Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Type (2022-2027) & (US$ Million) Table 114. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share Forecast by Type (2022-2027) Table 115. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2022-2027) & (K Units) Table 116. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Application (2022-2027) Table 117. Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Application (2022-2027) & (US$ Million) Table 118. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share Forecast by Application (2022-2027) Table 119. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2022-2027) & (K Units) Table 120. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Region (2022-2027) Table 121. Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Region (2022-2027) & (US$ Million) Table 122. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share Forecast by Region (2022-2027) Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Drug-Eluting Bioabsorbable Stents Figure 2. Global Drug-Eluting Bioabsorbable Stents Market Share by Type in 2020 & 2027 Figure 3. Serolimus and Paclitaxel Drug-Eluting Stents Product Picture Figure 4. Sirolimus Drug Eluting Stents Product Picture Figure 5. Global Drug-Eluting Bioabsorbable Stents Market Share by Application in 2020 & 2027 Figure 6. Coronary Artery Diseases Figure 7. Peripheral Artery Diseases Figure 8. Global Drug-Eluting Bioabsorbable Stents Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Drug-Eluting Bioabsorbable Stents Market Size 2016-2027 (US$ Million) Figure 10. Global Drug-Eluting Bioabsorbable Stents Sales 2016-2027 (K Units) Figure 11. Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturers in 2020 Figure 13. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest Drug-Eluting Bioabsorbable Stents Players: Market Share by Revenue in 2020 Figure 15. Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2016-2021) Figure 17. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2020 Figure 18. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2016-2021) Figure 19. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region in 2020 Figure 20. U.S. Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Canada Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Germany Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. France Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. U.K. Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Italy Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Russia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. China Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Japan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. South Korea Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. India Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Australia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Taiwan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Indonesia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Thailand Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Malaysia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Mexico Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Brazil Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Argentina Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Turkey Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Saudi Arabia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. UAE Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Sales Market Share of Drug-Eluting Bioabsorbable Stents by Type (2016-2021) Figure 43. Sales Market Share of Drug-Eluting Bioabsorbable Stents by Application (2016-2021) Figure 44. Sales Market Share of Drug-Eluting Bioabsorbable Stents by Application in 2020 Figure 45. Revenue Share of Drug-Eluting Bioabsorbable Stents by Application (2016-2021) Figure 46. Revenue Share of Drug-Eluting Bioabsorbable Stents by Application in 2020 Figure 47. Manufacturing Cost Structure of Drug-Eluting Bioabsorbable Stents Figure 48. Manufacturing Process Analysis of Drug-Eluting Bioabsorbable Stents Figure 49. Drug-Eluting Bioabsorbable Stents Industrial Chain Analysis Figure 50. Channels of Distribution Figure 51. Distributors Profiles Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Medtronic B.Braun Melsungen Abbott Laboratories Boston Scientific Corporation Biosensors International Terumo Corporation. MicroPort Scientific Corporation Alvimedica Biotronik Elixir Medical Corporation Innovative Health Technologies